reports
- Carole Braudeau
Credit Morning 05/07/2024
Monte has published a solid Q1 2024 results, above expectationsClariane has received a put option agreement for its HAD/SSIAD activities in FranceZalando: FY targets confirmed following a better-than-expected Q1, plans to buy back up to € 100m of convertible bonds due 2025Banco Sabadell rejects BBVA’s proposal>...
- Carole Braudeau
Morning Crédit 07/05/2024
Monte publie un T1 2024 solide, au-dessus des attentesZalando : objectifs confirmés à l’issue d’un T1 supérieur aux attentes, envisage des rachats d’obligations convertibles 2025 pour 100 m EUR maximumClariane a reçu une offre pour la cession de ses activités HAD/SSIAD en FranceBanco Sabadell rejette la proposition de fusion de BBVA>...
GSK: 1 director
A director at GSK sold 6,000 shares at 1,702p and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close p...
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
LHN LAFARGEHOLCIM LTD.
AC ACCOR SA
AMS AMS AG
SGO COMPAGNIE DE SAINT-GOBAIN SA
DG VINCI SA
ATO ATOS SE
BFIT BASIC-FIT NV
SK SEB SA
NXI NEXITY SA CLASS A
MF WENDEL SE
KORI KORIAN SA
CGM CEGEDIM SA
GRF GRIFOLS S.A. CLASS A
WIZZ WIZZ AIR HOLDINGS PLC
ERA ERAMET SA
DIC DIC ASSET AG
CLNX CELLNEX TELECOM S.A.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
- Carole Braudeau
LHN LAFARGEHOLCIM LTD.
AC ACCOR SA
AMS AMS AG
SGO COMPAGNIE DE SAINT-GOBAIN SA
DG VINCI SA
ATO ATOS SE
BFIT BASIC-FIT NV
SK SEB SA
NXI NEXITY SA CLASS A
MF WENDEL SE
KORI KORIAN SA
CGM CEGEDIM SA
GRF GRIFOLS S.A. CLASS A
WIZZ WIZZ AIR HOLDINGS PLC
ERA ERAMET SA
DIC DIC ASSET AG
CLNX CELLNEX TELECOM S.A.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Deri...
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C. The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The flagship Grifols campus is a touchstone of Grifols’ leadership in plasma therapeutics, producing about 40% of the company’s total medicinal output globally and helping enhance the quality of life of patients all over the worldAn engineering masterwork, the Clayton site is ...
- Carole Braudeau
- Carole Braudeau
- Carole Braudeau
Credit Morning 04/05/2024
Nexity obtains a waiver on its bank debt Clariane confirms that it is considering selling its HAD business in FranceSaur: in response to the sharp fall in results in 2023, S&P placed its BBB- rating on negative creditwatch and Fitch directly downgraded its rating to BB+.>...
- Carole Braudeau
Morning Crédit 05/04/2024
Nexity obtient un waiver sur sa dette bancaire. Clariane confirme que le groupe envisage de céder son activité HAD en France.Saur : réagissant à la forte baisse des résultats en 2023, S&P a placé son rating BBB- sous creditwatch négatif et Fitch a directement abaissé sa note à BB+.>...
Grifols Procleix ArboPlex Assay® erhält die CE-Zertifizierung – der er...
Grifols Procleix ArboPlex Assay® erhält die CE-Zertifizierung – der erste und einzige 4-in-1-Nukleinsäuretest zum Nachweis von Arboviren Der In-vitro-Nukleinsäuretest von Grifols weist vier Arten von Arboviren nach und trägt dazu bei, das Risiko transfusionsbedingter Infektionen zu verringernArboviren stellen eine wachsende Bedrohung dar, wobei der Klimawandel und die zunehmende globale Vernetzung die geografische Ausbreitung verstärkenDie CE-Zertifizierung für den Procleix ArboPlex Assay von Grifols unterstreicht die führende Rolle des Unternehmens in der Transfusionsmedizin und sein Engag...
Procleix ArboPlex Assay® di Grifols, primo e unico test NAT 4-in-1 per...
Procleix ArboPlex Assay® di Grifols, primo e unico test NAT 4-in-1 per lo screening degli arbovirus, riceve il marchio CE Il test NAT in vitro di Grifols rileva quattro tipi di arbovirus, contribuendo a ridurre il rischio di infezioni trasmesse tramite trasfusioneGli arbovirus sono una minaccia emergente in crescita, dato che i cambiamenti climatici e l'aumento della connettività globale ne incrementano la diffusione geograficaIl marchio CE per il Procleix ArboPlex Assay di Grifols rafforza la leadership dell'azienda nell’ambito della medicina trasfusionale e l'impegno a garantire la sicure...
Procleix ArboPlex Assay® da Grifols recebe a marca CE, o primeiro e ún...
Procleix ArboPlex Assay® da Grifols recebe a marca CE, o primeiro e único NAT 4 em 1 para o rastreio de arbovírus O teste de ácido nucleico in vitro da Grifols deteta quatro tipos de arbovírus, ajudando a reduzir o risco de infeções transmitidas por transfusãoOs arbovírus são uma ameaça emergente crescente, com as alterações climáticas e a crescente conetividade global a tornarem a propagação geográfica mais prevalenteA marca CE para o Procleix ArboPlex Assay da Grifols reforça a liderança da empresa na medicina transfusional e o seu empenho em garantir a segurança do abastecimento de sangu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.